Mayne Pharma Group Ltd (MYX) — Free Cash Flow Generation Index
Mayne Pharma Group Ltd (MYX) has a Free Cash Flow Generation Index of 0.78x as of June 2025. Free cash flow of AU$25.09 Million represents 1% of operating cash flow (AU$31.98 Million). See MYX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Mayne Pharma Group Ltd Free Cash Flow Generation Index (2010–2025)
Historical FCF Generation Index trend for Mayne Pharma Group Ltd across 12 annual periods. Explore MYX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Mayne Pharma Group Ltd (2010–2025)
Year-by-year Free Cash Flow Generation Index for Mayne Pharma Group Ltd. For the full company profile including market capitalisation, see MYX company net worth.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | AU$5.19 Million | AU$17.47 Million | AU$12.28 Million | ▼ -36.6% |
| 2021 | 0.47x | AU$22.16 Million | AU$47.26 Million | AU$25.10 Million | ▼ -11.2% |
| 2020 | 0.53x | AU$52.66 Million | AU$99.78 Million | AU$47.12 Million | ▼ -40.6% |
| 2019 | 0.89x | AU$94.69 Million | AU$106.61 Million | AU$11.91 Million | ▲ +60.3% |
| 2018 | 0.55x | AU$67.32 Million | AU$121.50 Million | AU$54.18 Million | ▲ +24.0% |
| 2016 | 0.45x | AU$23.91 Million | AU$53.50 Million | AU$29.59 Million | ▼ -45.1% |
| 2015 | 0.81x | AU$18.25 Million | AU$22.42 Million | AU$4.17 Million | ▼ -3.0% |
| 2014 | 0.84x | AU$21.93 Million | AU$26.14 Million | AU$4.20 Million | ▲ +140.4% |
| 2013 | -2.08x | AU$-14.21 Million | AU$6.84 Million | AU$21.06 Million | ▼ -356.4% |
| 2012 | 0.81x | AU$10.84 Million | AU$13.39 Million | AU$2.55 Million | ▲ +66.9% |
| 2011 | 0.49x | AU$1.98 Million | AU$4.09 Million | AU$2.10 Million | ▼ -49.5% |
| 2010 | 0.96x | AU$9.86 Million | AU$10.26 Million | AU$398.56K | — |